Hyperpigmented Macules and Patches on the Face: Exogenous Ochronosis or Lichen Planus Pigmentosus?
JDD authors Deepika Narayanan, MD and Stephen K. Tyring, MD, PhD, MBA present a case of a patient with a 10-year history of blue-black macules and patches on the face and an associated history of skin- lightening cream usage. The skin lightening cream contained hydroquinone, which is often associated with exogenous ochronosis (EO). Interestingly, the biopsy did not show characteristic findings of …
JDD authors Deepika Narayanan, MD and Stephen K. Tyring, MD, PhD, MBA present a case of a patient with a 10-year history of blue-black macules and patches on the face and an associated history of skin- lightening cream usage. The skin lightening cream contained hydroquinone, which is often associated with exogenous ochronosis (EO). Interestingly, the biopsy did not show characteristic findings of … 
As 2024 comes to a close, the Journal of Drugs in Dermatology delivers a stellar lineup of research, reviews, and insights to inform your practice and inspire your curiosity. This month's Editor's Picks feature cutting-edge studies and expert commentary on a range of topics, from advanced acne treatments to groundbreaking leadership initiatives in dermatology.
Laser and Energy Treatments for Ac … 
Are AI chatbots a wave of the future in dermatology? An article in the November Journal of Drugs in Dermatology assessed dermatologists’ attitudes and beliefs toward artificial intelligence chatbots. Chatbot usage has grown in a variety of areas of society in recent years, and ChatGPT’s popularity shows there’s demand. So to what extent do dermatologists think AI chatbots will play a role in … 
The November Journal of Drugs in Dermatology Editor's Picks spotlight the dynamic intersection of Lasers, Light Sources, and Devices in dermatology, featuring a mix of insightful studies and discussions. This month’s selections include an intriguing national survey capturing over 190 dermatologists' perspectives on the role of AI chatbots in dermatology, examining the potential applica … 
INTRODUCTION
Melanoma accounts for only 1% of all skin cancers but is responsible for most skin cancer-related deaths.1 Acral and mucosal melanoma (AMM) accounts for only 4% of all new melanomas but is associated with poorer prognosis.2 Patients of color are disproportionately affected by AMM. Elucidating the clinical, genetic, and environmental features of AMM can guide advancements in the … 